Investor Information
FirstVue Corporation Tallahassee FL (Privately Held) markets, develops, and contract manufactures rapid test medical devices using proprietary technologies; diagnostic products include immunoassays, in vitro tests and other rapid diagnostic medical devices. These products are sold in the United States and internationally to various clinical laboratories, government agencies, hospitals, clinics, community-based organizations and other public health organizations, distributors, physicians' offices, and commercial and industrial entities.
The FirstVue brand has emerged as leader in the hepatitus and drug medical device products for the advanced diagnosis of serious disease and health conditions. Their expertise is in the discovery of emerging diagnostic platforms and the successful commercialization of these products for use by medical community, institutions and consumers.
FirstVue's future is one of sustained growth with its now well known and regarded brand FirstVue™ and there ability in targeting significant market niche opportunities; estimated to be in excess of $9 billion worldwide in 2009. FirstVue has been recognized in “The Global Market for Point of Care Diagnostics Major Players and Key Issues” by Espicom Healthcare Intelligence. This industry report provides an extensive competitive comparison and evaluation of major and emerging companies and places FirstVue alongside such leaders as; Inverness Medical Innovations, Bayer Diagnostics and Siemens.
For more discussions on investors opportunites with our company please contact us....
FirstVue™ Corporation offers premium quality products or OEM contracts directly from our production facilities in California. Our company provides latest healthcare solutions to domestic and international clients. FirstVue™ is dedicated to ensuring that all products and services are of the highest quality and that all customers needs are taken care of correctly the first time, every time. The Customer Service Department can be reached by e-mail at 